Atlas Trials

Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

Clinical trial NCT02270788 · COMPLETED

Trial details

NCT number
NCT02270788
Sponsor
St. Jude Children's Research Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2015-04-02
Primary completion
2016-10-17
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.